Account
Leo Burnett wins duties for Adlabs Imagica
MUMBAI: After a multi-agency pitch, Leo Burnett India was given the mandate of handling the Adlabs Imagica brand, launched last year.
Apart from that, it will also be handling the duties for an upcoming yet to be named waterpark brand from the same house.
On the win, Leo Burnett India CEO Saurabh Varma said, “As a HumanKind agency, we are always looking for work that excites us, work that helps us connect with people and not just consumers. To be quite frank, we were excited at the prospect of partnering this brand which is so much fun.”
Adlabs Imagica has been focusing on customer care and a one-stop entertainment destination as a core for their communication. Driven by a whole world of fantastical themes to bring Indian families’ experiences that they have never had before, the park is a place ‘where stories come alive.’
Adlabs Imagica CEO Kapil Bagla was categorical in saying that, “As India’s first entertainment theme park, we were seeking a partner who would not only be vested in conventional communication but also help us create and develop an overall category for such a unique brand. We are looking forward to partnering with Leo Burnett to help offer complete wholesome entertainment experience to our guests.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
